You are here


At Pfizer Essential Health we combine our history of industry leadership, comprehensive knowledge of global healthcare markets, and vast portfolio of trusted, quality medicines to benefit patients around the world at virtually every stage of life.

Pfizer Innovative Health


At Pfizer, putting the patient first drives our passion, inspires us to collaborate, and motivates us to create and innovate. For the newly formed Pfizer Innovative Health, this belief represents something even more: it defines how we organize ourselves and evaluate performance. Most of all, it holds us accountable for creating a healthier world.

As a combined group – encompassing Consumer Healthcare, Inflammation & Immunology, Internal Medicine, Oncology, Rare Disease and Vaccines – Pfizer Innovative Health is committed to changing the outcome of chronic conditions and devastating diseases around the world. We are focused on improving health with our innovative products and vaccines — from prevention to treatment to wellness — at every stage of life in communities across the globe. Everything we do is to ensure that people have a chance to live longer, get stronger, and lead more vibrant lives.

See contact list Pfizer Innovative Health

Pfizer Essential Health


Pfizer Essential Health (PEH) medicines reach more than 300 million patients a year at virtually every stage of life. The depth and breadth of our portfolio of trusted medicines and capabilities, and our presence in 160 countries, enables us to deliver value to patients throughout the world.

Whether it’s using new technology and our deep experience to increase access to an essential medicine, or combating an emerging health risk, our ability to innovate and anticipate customer and patient needs allows us to make meaningful and inspired contributions to improving global health.

We are proud to provide access to our quality essential medicines to healthcare systems and patients in both developing and emerging markets. Pfizer Essential Health currently offers one of the industry’s largest and most diverse portfolios of anti-infectives; we’re number one in total biosimilar sales, and we’re a leader in off-patent sterile injectables and emerging markets. Our top global brands include trusted medicines such as Lipitor, Norvasc, Premarin, Viagra, and Celebrex.

Strategic Areas of Interest

Pfizer Essential Health Business Development actively seeks opportunities to partner and collaborate with companies that have novel ideas for differentiated products with potential for meaningful impact to patients. We are currently focusing on the sterile injectable hospital channel; the therapeutic area of anti-infectives; biosimilars; and branded products for the emerging markets.

We pride ourselves on being a creative, collaborative partner with a strong foundation in integrity, trust, and respect in all our partner relationships. We welcome all inquiries about potential opportunities and are committed to a timely response.

See contact list Pfizer Essential Health